Thomas H. Burkey

1.3k total citations
18 papers, 1.0k citations indexed

About

Thomas H. Burkey is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Thomas H. Burkey has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Thomas H. Burkey's work include Neuropeptides and Animal Physiology (10 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). Thomas H. Burkey is often cited by papers focused on Neuropeptides and Animal Physiology (10 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). Thomas H. Burkey collaborates with scholars based in United States, Japan and Belgium. Thomas H. Burkey's co-authors include William R. Roeske, Henry I. Yamamura, Paul Consroe, Raymond M. Quock, Robert S Landsman, Yoshiaki Hosohata, Keiko Hosohata, Éva Varga, John W. Regan and Frederick J. Ehlert and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Pain and Pharmacological Reviews.

In The Last Decade

Thomas H. Burkey

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas H. Burkey United States 15 687 489 427 216 101 18 1.0k
Ana M. Martín‐Moreno Spain 12 418 0.6× 638 1.3× 383 0.9× 224 1.0× 155 1.5× 12 1.3k
Thierry Groblewski Canada 12 647 0.9× 430 0.9× 600 1.4× 344 1.6× 125 1.2× 17 1.4k
Angelo Vaccani Italy 11 404 0.6× 860 1.8× 299 0.7× 94 0.4× 113 1.1× 15 1.2k
Xavier Canat France 11 919 1.3× 969 2.0× 486 1.1× 125 0.6× 210 2.1× 12 1.6k
Somnath Mukhopadhyay United States 21 637 0.9× 904 1.8× 373 0.9× 77 0.4× 146 1.4× 31 1.3k
Angela B. Clement Germany 11 219 0.3× 358 0.7× 214 0.5× 123 0.6× 74 0.7× 11 656
Irene Sánchez-Vera Spain 9 296 0.4× 304 0.6× 210 0.5× 103 0.5× 66 0.7× 9 914
Natasha L. Grimsey New Zealand 16 489 0.7× 698 1.4× 342 0.8× 59 0.3× 97 1.0× 34 935
Alvin R. King United States 8 331 0.5× 399 0.8× 289 0.7× 61 0.3× 77 0.8× 8 716
Barbara Bosier Belgium 16 345 0.5× 418 0.9× 203 0.5× 63 0.3× 57 0.6× 20 651

Countries citing papers authored by Thomas H. Burkey

Since Specialization
Citations

This map shows the geographic impact of Thomas H. Burkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Burkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Burkey more than expected).

Fields of papers citing papers by Thomas H. Burkey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas H. Burkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Burkey. The network helps show where Thomas H. Burkey may publish in the future.

Co-authorship network of co-authors of Thomas H. Burkey

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas H. Burkey. A scholar is included among the top collaborators of Thomas H. Burkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas H. Burkey. Thomas H. Burkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fehrenbacher, Jill C., Thomas H. Burkey, Grant D. Nicol, & Michael R. Vasko. (2004). Tumor necrosis factor α and interleukin-1β stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells. Pain. 113(1). 113–122. 64 indexed citations
2.
Hosohata, Yoshiaki, Todd W. Vanderah, Thomas H. Burkey, et al.. (2000). δ-Opioid receptor agonists produce antinociception and [35S]GTPγS binding in μ receptor knockout mice. European Journal of Pharmacology. 388(3). 241–248. 51 indexed citations
3.
Hosohata, Keiko, Jennifer Logan, Éva Varga, et al.. (2000). The role of the G protein γ2 subunit in opioid antinociception in mice. European Journal of Pharmacology. 392(3). R9–R11. 14 indexed citations
4.
Okura, Takashi, Scott Cowell, Éva Varga, et al.. (2000). Differential down-regulation of the human δ-opioid receptor by SNC80 and [d-Pen2,d-Pen5]enkephalin. European Journal of Pharmacology. 387(2). R11–R13. 21 indexed citations
5.
Hosohata, Keiko, et al.. (1999). (2S,3R)TMT-l-Tic-OH is a potent inverse agonist at the human δ-opioid receptor. European Journal of Pharmacology. 380(1). R9–R10. 18 indexed citations
6.
Quock, Raymond M., Thomas H. Burkey, Éva Varga, et al.. (1999). The δ-Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy. Pharmacological Reviews. 51(3). 503–532. 79 indexed citations
7.
Quock, Raymond M., Thomas H. Burkey, Éva Varga, et al.. (1999). The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy.. PubMed. 51(3). 503–32. 135 indexed citations
8.
Burkey, Thomas H., Frederick J. Ehlert, Yoshiaki Hosohata, et al.. (1998). The efficacy of δ-opioid receptor-selective drugs. Life Sciences. 62(17-18). 1531–1536. 13 indexed citations
9.
Hosohata, Keiko, Thomas H. Burkey, Éva Varga, et al.. (1998). Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptor. European Journal of Pharmacology. 346(1). 111–114. 54 indexed citations
10.
Burkey, Thomas H., Raymond M. Quock, Paul Consroe, William R. Roeske, & Henry I. Yamamura. (1997). Δ9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain. European Journal of Pharmacology. 323(2-3). R3–R4. 58 indexed citations
11.
Quock, Raymond M., Yoshiaki Hosohata, Richard J. Knapp, et al.. (1997). Relative efficacies of δ-opioid receptor agonists at the cloned human δ-opioid receptor. European Journal of Pharmacology. 326(1). 101–104. 31 indexed citations
12.
Landsman, Robert S, Thomas H. Burkey, Paul Consroe, William R. Roeske, & Henry I. Yamamura. (1997). SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. European Journal of Pharmacology. 334(1). R1–R2. 231 indexed citations
13.
Hosohata, Keiko, Raymond M. Quock, Yoshiaki Hosohata, et al.. (1997). AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain. Life Sciences. 61(9). PL115–PL118. 45 indexed citations
14.
Burkey, Thomas H., Raymond M. Quock, Paul Consroe, et al.. (1997). Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. European Journal of Pharmacology. 336(2-3). 295–298. 77 indexed citations
15.
Burkey, Thomas H., et al.. (1995). 6-isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist. Biochemical Pharmacology. 50(10). 1731–1733. 96 indexed citations
16.
Burkey, Thomas H. & John W. Regan. (1995). Activation of Mitogen-Activated Protein Kinase by the Human Prostaglandin EP3A Receptor. Biochemical and Biophysical Research Communications. 211(1). 152–158. 20 indexed citations
17.
Burkey, Thomas H. & Robert O. Webster. (1993). Adenosine inhibits fMLP-stimulated adherence and superoxide anion generation by human neutrophils at an early step in signal transduction. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1175(3). 312–318. 27 indexed citations
18.
Farmer, Joseph C., Thomas H. Burkey, Richard R. Kew, & Robert O. Webster. (1991). Concentration-dependent Regulatory Effects of Prostaglandin E 1 on Human Neutrophil function In Vitro. American Review of Respiratory Disease. 144(3_pt_1). 593–599. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana M. Martín‐Moreno Breakdown of academic impact, for papers by Thierry Groblewski Breakdown of academic impact, for papers by Angelo Vaccani Breakdown of academic impact, for papers by Xavier Canat Breakdown of academic impact, for papers by Somnath Mukhopadhyay Breakdown of academic impact, for papers by Angela B. Clement Breakdown of academic impact, for papers by Irene Sánchez-Vera Breakdown of academic impact, for papers by Natasha L. Grimsey Breakdown of academic impact, for papers by Alvin R. King Breakdown of academic impact, for papers by Barbara Bosier
Rankless by CCL
2026